584 related articles for article (PubMed ID: 23160112)
21. [Long-term lithium prophylaxis in the bipolar affective disorder].
Suwalska A; Chłopocka-Woźniak M; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
[TBL] [Abstract][Full Text] [Related]
22. Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study.
Muti M; Del Grande C; Musetti L; Marazziti D; Pergentini I; Corsi M; Turri M; Umberto Corsini G; Dell'Osso L
Int Clin Psychopharmacol; 2013 Nov; 28(6):305-11. PubMed ID: 23873290
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
[TBL] [Abstract][Full Text] [Related]
24. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
Tohen M; Wang WV; Leboyer M; Jen KY
J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
[TBL] [Abstract][Full Text] [Related]
25. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
26. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
Thase ME
J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
[TBL] [Abstract][Full Text] [Related]
27. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
[TBL] [Abstract][Full Text] [Related]
28. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
[TBL] [Abstract][Full Text] [Related]
29. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
[TBL] [Abstract][Full Text] [Related]
30. Bipolar II disorder: arguments for and against a distinct diagnostic entity.
Vieta E; Suppes T
Bipolar Disord; 2008 Feb; 10(1 Pt 2):163-78. PubMed ID: 18199235
[TBL] [Abstract][Full Text] [Related]
31. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
32. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
33. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
34. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
35. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.
Baldessarini RJ; Tondo L; Floris G; Hennen J
J Affect Disord; 2000 Dec; 61(1-2):13-22. PubMed ID: 11099736
[TBL] [Abstract][Full Text] [Related]
36. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
[TBL] [Abstract][Full Text] [Related]
37. Post-acute effectiveness of lithium in pediatric bipolar I disorder.
Findling RL; Kafantaris V; Pavuluri M; McNamara NK; Frazier JA; Sikich L; Kowatch R; Rowles BM; Clemons TE; Taylor-Zapata P
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):80-90. PubMed ID: 23510444
[TBL] [Abstract][Full Text] [Related]
38. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
[TBL] [Abstract][Full Text] [Related]
39. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment.
Özerdem A; Tunca Z; Çımrın D; Hıdıroğlu C; Ergör G
Bipolar Disord; 2014 Feb; 16(1):72-82. PubMed ID: 24330379
[TBL] [Abstract][Full Text] [Related]
40. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
